Please login to the form below

Not currently logged in
Email:
Password:

European Respiratory Society

This page shows the latest European Respiratory Society news and features for those working in and with pharma, biotech and healthcare.

Sanofi and Regeneron share positive data for asthma drug

Sanofi and Regeneron share positive data for asthma drug

The late-breaking data was presented at the European Respiratory Society (ERS) 2022 congress and demonstrated a consistent safety profile and efficacy for up to two years for children in this ... The safety results of the trial were generally consistent

Latest news

More from news
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Follow the user – democratising medical conference design Follow the user – democratising medical conference design

    increased incrementally, the curve of the European Respiratory Society congress (22, 094 vs 33, 784) saw its 2019 demographic increased by more than 50%. ... Another look at the 2020 European Respiratory Society statistics illustrates the high value

  • Exploring the potential of eosinophils Exploring the potential of eosinophils

    This study was the first to investigate an anti-IL-5 therapy in patients with nasal polyps and the data was presented for the first time at the European Respiratory Society ... GSK has an extraordinary heritage in respiratory research to try to benefit

  • GSK forges ahead with its dynamic COPD and asthma portfolio GSK forges ahead with its dynamic COPD and asthma portfolio

    Other patient and clinical interest groups put the figure even higher, with the European Respiratory Society placing the number at 300 million, with figures rising higher in nations with poor access ... COPD was a Cinderella disease when I started in

  • The long and winding road to asthma breakthroughs The long and winding road to asthma breakthroughs

    Respiratory biologics are booming thanks to scientists who refused to be derailed by early research setbacks. ... The company’s severe eosinophilic asthma biologic Nucala (mepoluzimab), an Interleukin-5 inhibitor, has been buoyed by a real-world

  • Case Study: COPD Crowdshaped Case Study: COPD Crowdshaped

    At the European Respiratory Society (ERS) congress 2015, we convened the world’s first three-university simultaneous hackathon with over 400 participants from Massachusetts Institute of Technology (MIT), Imperial College London

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wave Healthcare Communications

Wave combine scientific, medical and brand expertise to deliver clinically focused programmes that are trusted by HCPs, drive better patient...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...